Molecular modelling of hepatitis B virus polymerase: Comparison of adefovir, entecavir and lamivudine resistance

被引：0
|
作者：
Bartholomeusz, A
Locarnini, S
Colledge, D
Ayres, A
Kuiper, M
Chalmers, D
机构：
[1] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[2] Victorian Partnership Adv Comp, Melbourne, Vic, Australia
[3] Vic Coll Pharm, Parkville, Vic, Australia
来源：
ANTIVIRAL RESEARCH | 2004年 / 62卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
49
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [1] Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance
    Yang, Hyo-Joon
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (03) : 424 - 430
  • [2] Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Heo, Nae-Yun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 449 - 454
  • [3] Molecular modelling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations
    Bartholomeusz, A
    Locarnini, SA
    Ayres, A
    Thompson, G
    Sozzi, V
    Angus, P
    Sievert, W
    Sasadeusz, J
    Chalmers, D
    Cooper, M
    HEPATOLOGY, 2004, 40 (04) : 246A - 246A
  • [4] Susceptibility of Hepatitis B Virus to Lamivudine Restored by Resistance to Adefovir
    Zaaijer, H. L.
    Takkenberg, R. B.
    Weegink, C. J.
    Rebers, S. P. H.
    Menting, S.
    Reesink, H. W.
    Schinkel, J.
    Molenkamp, R.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 413 - 416
  • [5] ENTECAVIR MONOTHERAPY VERSUS ENTECAVIR PLUS ADEFOVIR COMBINATION FOR CHRONIC HEPATITIS B PATIENTS WITH SEQUENTIAL LAMIVUDINE-ADEFOVIR RESISTANCE
    Lee, Sun Jae
    Lee, Hyun Jung
    Yoon, Eileen
    Suh, Sang Jun
    Kim, Jeong Han
    Choe, Won Hyeok
    Kim, Ji Hoon
    Seo, Yeon Seok
    Yim, Hyung Joon
    Kwon, So Young
    Yeon, Jong Eun
    Lee, Chang Hong
    Byun, Kwan Soo
    HEPATOLOGY, 2011, 54 : 1031A - 1031A
  • [6] Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir
    Choe, Won Hyeok
    Hong, Sun Pyo
    Kim, Byung Kook
    Ko, Soon Young
    Jung, Young Kul
    Kim, Ji Hoon
    Yeon, Jong Eun
    Byun, Kwan Soo
    Kim, Kyun-Hwan
    Ji, Seung Il
    Kim, Soo-Ok
    Lee, Chang Hong
    Kwon, So Young
    ANTIVIRAL THERAPY, 2009, 14 (07) : 985 - 993
  • [7] Adefovir treatment of entecavir resistance in patients with lamivudine-refractory chronic hepatitis B
    Yurdaydin, C.
    Idilman, R.
    Cevik, E.
    Akarca, U. S.
    Kaymakoglu, S.
    Bozdayi, A. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S255 - S255
  • [8] Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B
    Heo, Jeong
    Ahn, Sang Hoon
    Kweon, Young-Oh
    Kim, Byung-Ho
    Chan, Henry L. Y.
    Horban, Andrzej
    Wongcharatrawee, Suchat
    Llamoso, Cyril
    Lee, Kwan Sik
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) : 1485 - 1493
  • [9] Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir
    Walsh, Ann W.
    Langley, David R.
    Colonno, Richard J.
    Tenney, Daniel J.
    PLOS ONE, 2010, 5 (02):
  • [10] A comparison of entecavir monotherapy versus entecavir plus adefovir combination therapy for up to 96 weeks in adefovir refractory chronic Hepatitis B patients with prior lamivudine resistance
    Kim, In Hee
    Seo, Seung Young
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    HEPATOLOGY, 2012, 56 : 391A - 391A
12345